References
- Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA, Coester C, Tuomi T, Rehberg M, Krombach F. 2008. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol 5:14.
- Castellan RM, Olenchock SA, Kinsley KB, Hankinson JL. 1987. Inhaled endotoxin and decreased spirometric values: An exposure-response relation for cotton dust. N Engl J Med 317:605–610.
- Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE. 1991. Endotoxemia in human septic shock. Chest 99;169–175.
- Douwes JD, Versloot P, Hollander A, Heedrik D, Doekes G. 1995. Influence of various dust sampling and extraction methods on the measurement of airborne endotoxin. Appl Environ Microbiol 61(5):1763–1769.
- Inoue K-I, Takano H, Yanagisawa R, Hirano S, Sakurai M, Shimada A, Yoshikawa T. 2006. Effects of airway exposure to nanoparticles on lung inflammation induced by bacterial endotoxin in mice. Environ Health Perspect 114(9):1325–1330.
- ISO. 2009. Accessed 16 January 2009 from the website: http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=45640.
- Jacobs RJ. 1989. Airborne endotoxins: An association with occupational lung disease. Appl Ind Hyg 4(2):50–56.
- Magalhães PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TCV, Pessoa A Jr. 2007. Methods of endotoxin removal from biological preparations: A review. J Pharm Pharmaceut Sci 10(3):271–287.
- Maynard A, Kuempel ED. 2005. Airborne nanostructured particles and occupational health. J Nanopart Res 7:587–614.
- Maynard A. 2006. Woodrow Wilson International Center for Scholars: Project on Emerging Nanotechnologies, Nanotechnology: A Research Strategy for Addressing Risk; July:35.
- Michel O, Kips J, Duchateua J, Vertongen F, Robert L, Collet H, Pauwels R, Sergysels R. 1996. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 154:1641–1646.
- Park J, Gold D, Spiegelman D, Burge H, Milton D. 2001. House dust endotoxin and wheeze in the first year of life. Am J Respir Crit Care Med 163:322–328.
- Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles Environ Health Perspect13(7):823–839.
- Rylander R, Bake B, Fischer JJ, Helander IM. 1989. Pulmonary function and symptoms after inhalation of endotoxin. Am Rev Respir Dis 140:981–986.
- Schwartz DA. 2001. Does inhalation of endotoxin cause asthma? Am J Respir Crit Care Med 163:305–313.
- United States Food and Drug Administration (USFDA). 1985. Bacterial endotoxins/pyrogens. Inspector’s Technical Guide No. 40.
- Vallhov H, Qin J, Johansson SM, Ahlborg N, Muhammed MA, Scheynius A, Gabrielsson S. 2006. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett 6:8.
- Wanderley A, Wanderley C. 1998. Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications – Brazil, 1996. CDC Morbidity Mortality Weekly Rep July 31;47(29);610–612.
- Wolff SM. 1973. Biological effects of bacterial endotoxins in man. J Inf Dis 128(Suppl.):S259–264.